Potential utility of p63 expression in differential diagnosis of non-small-cell lung carcinoma and its effect on prognosis of the disease

Creative Commons License

Bir F., AKSOY ALTINBOĞA A., TUFAN N. L., Kaya S., BAŞER S., YAREN A.

MEDICAL SCIENCE MONITOR, cilt.20, ss.219-226, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20
  • Basım Tarihi: 2014
  • Doi Numarası: 10.12659/msm.890394
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.219-226
  • Anahtar Kelimeler: Carcinoma, Non-Small-Cell Lung - pathology, Diagnosis, Differential, Reverse Transcriptase Polymerase Chain Reaction - methods, IMMUNOHISTOCHEMICAL MARKERS, P53 HOMOLOG, CANCER, CLASSIFICATION, ADENOCARCINOMA, EPITHELIUM, SURVIVAL, P73
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Background: P63 is a gene located in chromosome 3q27-29, which has been implicated in regulation of stem cell commitment and promotion of squamous differentiation in various tissues. The aim of this study was to investigate whether there was a correlation between p63 expression, differential diagnosis of lung carcinoma, and prognosis.